Update in thrombosis and cancer;Actualités en thrombose et cancer

Revue de Medecine Interne

Volumn 32, Issue 4, 2011, Pages 265-267

  Geffray, L ^a  

^a Centre Hospitalier Robert Bisson   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANGIOGENIC THERAPY; ANTICOAGULANT THERAPY; CONFERENCE PAPER; NEOPLASM; PATHOPHYSIOLOGY; THROMBOCYTOPENIA; THROMBOSIS; VENOUS THROMBOEMBOLISM;

AGE FACTORS; ANTINEOPLASTIC AGENTS; CONGRESSES AS TOPIC; FRANCE; HUMANS; INCIDENCE; INTERNAL MEDICINE; NEOPLASMS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; VENOUS THROMBOEMBOLISM;

EID: 79953316820     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2011.01.010     Document Type: Conference Paper

References (7)

1. Di Nisio M., Otten H.M., Piccioli A., Lensing A.W., Prandoni P., Büller H.R., et al. Decision analysis for cancer screening in idiopathic venous thromboembolism. J Thromb Haemost 2005, 3:2391-2396.
2. Khorana A.A., Kuderer N.M., Culakova E., Lyman G.H., Francis C.W. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 2008, 111:4902-4907.
3. Lee A.Y., Rickles F.R., Julian J.A., Gent M., Baker R.I., Bowden C., et al. Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism. J Clin Oncol 2005, 23:2123-2129.
4. Hull R.D., Pineo G.F., Brant R.F., Mah A.F., Burke N., Dear R., et al. Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer. Am J Med 2006, 119:1062-1072.
5. Farge D., Durant C., Villiers S., Long A., Mahr A., Marty M., et al. Lessons from French National Guidelines on the treatment of venous thrombosis and central venous catheter thrombosis in cancer patients. Thromb Res 2010, 125(Suppl. 2):S108-S116.
6. Stein P.D., Beemath A., Meyers F.A., Skaf E., Sanchez J., Olson R.E. Incidence of venous thromboembolism in patients hospitalized with cancer. Am J Med 2006, 119:60-68.
7. Palumbo A., Rajkumar S.V., Dimopoulos M.A., Richardson P.G., San Miguel J., Barlogie B., et al. Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma. Leukemia 2008, 22:414-423.